Glucose control in acute myocardial infarction: A pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care

Diabetes Technology and Therapeutics

Volumn 14, Issue 2, 2012, Pages 117-124

  Sampaio, Célia R ^a,b   Franco, Denise R ^b,c   Goldberg, David J ^d,e   Baptista, Juliana ^b,c   Eliaschewitz, Freddy Goldberg ^b,f  

^a SEPACO Hospital   (Brazil)

^b CPCLIN Clinical Research Center   (Brazil)

^c Juvenile Diabetes Association   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Verax S/C Ltda   (Brazil)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING DRUG; PIG INSULIN; SULFONYLUREA;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD GLUCOSE MONITORING; CAPILLARY BLOOD; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING SYSTEM; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; EXPLORATORY RESEARCH; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MALE; MONITORING, AMBULATORY; MYOCARDIAL INFARCTION; PILOT PROJECTS; STANDARD OF CARE; TIME FACTORS; UNITED STATES;

EID: 84855839898     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0157     Document Type: Article

References (27)

1. Devos P, Chiolero R, Van den Berghe G, Preiser JC: Glucose, insulin and myocardial ischaemia. Curr Opin Clin Nutr Metab Care 2006;9:131-139. (Pubitemid 44090037)
2. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-1754. (Pubitemid 35341952)
3. Kavanagh BP, McCowen KC: Clinical practice. Glycemic control in the ICU. N Engl J Med 2010;363:2540-2546.
4. Chaudhuri A, Miller M, Nesto R, Rosenberg N, Dandona P: Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target? Diabetes Care 2007;30:3026-3028. (Pubitemid 350255237)
5. Gan RM, Wong V, Cheung NW, McLean M: Effect of insulin infusion on electrocardiographic findings following acute myocardial infarction: importance of glycaemic control. Diabet Med 2009;26:174-176.
6. Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, O'Neill W, Grines CL; Primary Angioplasty in Myocardial Infarction (PAMI) Investigators: Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpa-tients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1739-1746. (Pubitemid 37433651)
7. Cheung NW, Wong VW, McLean M: The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-770. (Pubitemid 44115291)
8. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
9. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA: Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008;117:1018-1027.
10. Kosiborod M, Deedwania P: An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol 2009;3:1342-1351.
11. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314: 1512-1515. (Pubitemid 27216066)
12. Louie K, Cheema R, Dodek P, Wong H, Wilmer A, Grubisic M, Fitzgerald JM, Ayas NT: Intensive nursing work schedules and the risk of hypoglycaemia in critically ill patients who are receiving intravenous insulin. Qual Saf Health Care 2010;19:e42.
13. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661. (Pubitemid 40516876)
14. Rosskamp RH, Park G: Long-acting insulin analogs. Diabetes Care 1999;22(Suppl 2):B109-B113. (Pubitemid 29107159)
15. Ashwell SG, Gebbie J, Home PD: Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Diabet Med 2006; 23:879-886. (Pubitemid 44141077)
16. Franco DRB, Abreu FRM, Batista RB, Alves MRC, Eliaschewitz FG: Initial dose of insulin glargine in type 2 diabetes based on BMI is safe [abstract]. Diabetologia 2008;51(Suppl 1):S394-S395.
17. Service FJ, Nelson RL: Characteristics of glycemic stability. Diabetes Care 1980;3:58-62. (Pubitemid 10079157)
18. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
19. Rood E, Bosman RJ, van der Spoel JI, Taylor P, Zandstra DF: Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2005;12:172-180. (Pubitemid 40298952)
20. Lucidi P, Porcellati F, Rossetti P, Candeloro P, Cioli P, Marzotti S, Andreoli AM, Fede R, Bolli GB, Fanelli CG: Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study. Diabetes Care 2011;34:1312-1314.
21. Weber KK, Lohmann T, Busch K, Donati-Hirsch I, Riel R: High frequency of unrecognized hypoglycaemias in patients with Type 2 diabetes is discovered by continuous glucose monitoring. Exp Clin Endocrinol Diabetes 2007;115:491-494. (Pubitemid 350056760)
22. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002; 25:889-893. (Pubitemid 41094288)
23. Barnett AH, Cradock S, Fisher M, Hall G, Hughes E, Mid-dleton A: Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract 2010;64:1121-1129.
24. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M: Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010;85:217-224.
25. Rana O, Byrne CD, Greaves K. Intensive insulin therapy in the intensive care unit, hypoglycemia, and cardiovascular mortality. Hosp Pract (Minneap) 2010;38:59-66.
26. Giménez M, Gilabert R, Monteagudo J, Alonso A, Casa-mitjana R, Paré C, Conget I: Repeated episodes of hypo-glycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with T1D. Diabetes Care 2011; 34:198-203.
27. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA: Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009;301:1556-1564.